HEALTHX
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price below most MAs — downtrend
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹282.1 Cr | ₹278.7 Cr | ₹309 Cr | ₹341.5 Cr |
| Net Profit | ₹13.7 Cr | ₹23.9 Cr | ₹-12.7 Cr | ₹1.1 Cr |
| EPS | — | ₹7.52 | ₹-3.99 | ₹0.35 |
| Operating Profit | ₹-14.1 Cr | ₹31.4 Cr | ₹-17.3 Cr | ₹3.3 Cr |
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Sept 2024 | Annual General Meeting | AGM |
| 22 Sept 2023 | Annual General Meeting | AGM |
| 21 Sept 2022 | Annual General Meeting | AGM |
| 20 Sept 2021 | Annual General Meeting | AGM |
| 03 Sept 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for HEALTHX
View All
Paras Healthcare plans ₹1,800 crore IPO, files draft papers with Sebi
Paras Healthcare Ltd, which operates hospitals under the 'Paras Health' brand, has filed preliminary papers with capital markets regulator Sebi to raise up to Rs 1,800 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an Offer-For-Sale (OFS) of equity shares worth up to Rs 1,300 crore by the selling shareholder, according to the draft red herring prospectus (DRHP) filed on Thursday. Those selling shares include promoter Dharminder Kumar Nagar and other investors. The Gurugram-based company intends to utilise the proceeds from the fresh issue towards prepayment or repayment of certain outstanding borrowings, investment in its wholly-owned subsidiary PMHPL for its debt payment, and for general corporate purposes. Paras Healthcare is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate capacity of